We demonstrate that an individual intratumoral injection of XVir-N-31 induced ICD and enhanced the number of tumor infiltrating lymphocytes (TILs). Both effects were being even more elevated if a blockade on the PD-1/PD-L1 axis was assembled. According to our previous and recent data, a scientific trial making use of XVir-N-31 to treat recurrent GB